Enhanced NO signaling in patients with takotsubo cardiomyopathy: Short-term pain, long-term gain?

Cardiovascular Drugs and Therapy

Volumn 27, Issue 6, 2013, Pages 541-547

  Nguyen, Thanh H ^a   Neil, Christopher J ^a   Sverdlov, Aaron L ^a   Ngo, Doan T ^a   Chan, Wai P ^a   Heresztyn, Tamila ^a   Chirkov, Yuliy Y ^a   Tsikas, Dimitrios ^b   Frenneaux, Michael P ^c   Horowitz, John D ^a,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Asymmetric dimethylarginine; Nitric oxide signaling; Platelet responsiveness to NO; Takotsubo cardiomyopathy

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE;

AGED; AGING; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REDOX STRESS; SIGNAL TRANSDUCTION; TAKOTSUBO CARDIOMYOPATHY; THROMBOCYTE AGGREGATION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PAIN; SIGNAL TRANSDUCTION; TAKOTSUBO CARDIOMYOPATHY;

EID: 84892365821     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-013-6481-x     Document Type: Article

References (47)

1. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141:858-65.
2. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J. 2006;27:1523-9.
3. Pilliere R, Mansencal N, Digne F, Lacombe P, Joseph T, Dubourg O. Prevalence of Tako-Tsubo syndrome in a large urban agglomeration. Am J Cardiol. 2006;98:662-5.
4. Sharkey SW, Windenburg DC, Lesser JR, Maron MS, Hauser RG, Lesser JN, et al. Natural history and expansive clinical profile of stress (Tako-Tsubo) cardiomyopathy. J Am Coll Cardiol. 2010;55:333-41.
5. Akashi Y. Reversible ventricular dysfunction takotsubo (ampullashaped) cardiomyopathy. Intern Med. 2005;44:175-6.
6. Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50:448-52.
7. Akashi YJ, Nakazawa K, Sakakibara M, Miyake F, Koike H, Sasaka K. The clinical features of takotsubo cardiomyopathy. QJM. 2003;96:563-73.
8. Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352:539-48.
9. Yoshioka T, Hashimoto A, Tsuchihashi K, Nagao K, Kyuma M, Ooiwa H, et al. Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-Tsubo cardiomyopathy). Am Heart J. 2008;155:526 e1-7.
10. Mallamaci F, Tripepi G, Maas R, Malatino L, Boger R, Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol. 2004;15:435-41.
11. Lee CW, Li D, Channon KM, Paterson DJ. L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats. J Mol Cell Cardiol. 2009;47:149-55.
12. Chan NY, Seyedi N, Takano K, Levi R. An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition. Circulation. 2012;125:298-307.
13. Zhu WZ, Zheng M, Koch WJ, Lefkowitz RJ, Kobilka BK, Xiao RP. Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. Proc Natl Acad Sci U S A. 2001;98:1607-12.
14. Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P, et al. High levels of circulating epinephrine trigger apical cardiodepression in a beta2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation. 2012;126:697-706.
15. Grant JF, Chittleborough CR, Taylor AW, Dal Grande E, Wilson DH, Phillips PJ, et al. The North West Adelaide Health Study: detailed methods and baseline segmentation of a cohort for selected chronic diseases. Epidemiol Perspect Innov. 2006;3:4.
16. Chirkov YY, Holmes AS, Willoughby SR, Stewart S, Wuttke RD, Sage PR, et al. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol. 2001;37:1851-7.
17. Boger RH. Asymmetric dimethylarginine (ADMA) modulates endothelial function-therapeutic implications. Vasc Med. 2003;8:149-51.
18. Fleissner F, Thum T. Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. Antioxid Redox Signal. 2011;15:933-48.
19. Chirkov YY, Holmes AS, Chirkova LP, Horowitz JD. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation. 1999;100:129-34.
20. Heresztyn T, Worthley MI, Horowitz JD. Determination of l-arginine and NG, NG - and NG, NG' -dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;805:325-9.
21. Rajendran S, Willoughby SR, Chan WP, Liberts EA, Heresztyn T, Saha M, et al. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis. 2009;204:509-14.
22. Lagerstedt SA, O'Kane DJ, Singh RJ. Measurement of plasma free metanephrine and normetanephrine by liquid chromatographytandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem. 2004;50:603-11.
23. Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, et al. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Am J Cardiol. 2011;108:1316-21.
24. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-67.
25. Neil C, Nguyen TH, Kucia A et al. Slowly resolving global myocardial inflammation/oedema in Tako-Tsubo cardiomyopathy: evidence from T2-weighted cardiac MRI. Heart (British Cardiac Society) 2012;98:1278-84.
26. Nef HM, Mollmann H, Hilpert P, Troidl C, Voss S, Rolf A, et al. Activated cell survival cascade protects cardiomyocytes from cell death in Tako-Tsubo cardiomyopathy. Eur J Heart Fail. 2009;11:758-64.
27. Forbes SP, Druhan LJ, Guzman JE, Parinandi N, Zhang L, Green- Church KB, et al. Mechanism of 4-HNE mediated inhibition of hDDAH-1: implications in no regulation. Biochemistry. 2008;47:1819-26.
28. Pope AJ, Druhan L, Guzman JE, Forbes SP, Murugesan V, Lu D, et al. Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation. Am J Physiol Cell Physiol. 2007;293:C1679-86.
29. Fiedler L. The DDAH/ADMA pathway is a critical regulator of NO signalling in vascular homeostasis. Cell Adh Migr. 2008;2:149-50.
30. Stuhlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569-75.
31. Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, et al. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J. 2009;30:1142-50.
32. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008;155:408-17.
33. Anfossi G, Russo I, Massucco P, Mattiello L, Trovati M. Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. Thromb Haemost. 2002;87:539-40.
34. Ozuyaman B, Godecke A, Kusters S, Kirchhoff E, Scharf RE, Schrader J. Endothelial nitric oxide synthase plays a minor role in inhibition of arterial thrombus formation. Thromb Haemost. 2005;93:1161-7.
35. Chirkov YY, Horowitz JD. Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?. Pharmacol Ther. 2007;116:287-305.
36. Zhang F, Chen L, Liu C, Qiu P, Wang A, Li L, et al. Up-regulation of protein tyrosine nitration in methamphetamine-induced neurotoxicity through DDAH/ADMA/NOS pathway. Neurochem Int. 2013;62:1055-64.
37. Kume T, Kawamoto T, Okura H, Toyota E, Neishi Y, Watanabe N, et al. Local release of catecholamines from the hearts of patients with Tako-Tsubo-like left ventricular dysfunction. Circ J. 2008;72:106-8.
38. Penna C, Bassino E, Alloatti G. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. Exp Biol Med (Maywood). 2011;236:390-401.
39. Barletta G, Del Pace S, Boddi M, Del Bene R, Salvadori C, Bellandi B, et al. Abnormal coronary reserve and left ventricular wall motion during cold pressor test in patients with previous left ventricular ballooning syndrome. Eur Heart J. 2009;30:3007-14.
40. Martin EA, Prasad A, Rihal CS, Lerman LO, Lerman A. Endothelial function and vascular response to mental stress are impaired in patients with apical ballooning syndrome. J Am Coll Cardiol. 2010;56:1840-6.
41. Song BG, Park SJ, Noh HJ, Jo HC, Choi JO, Lee SC, et al. Clinical characteristics, and laboratory and echocardiographic findings in takotsubo cardiomyopathy presenting as cardiogenic shock. J Crit Care. 2010;25:329-35.
42. Boucher JL, Moali C, Tenu JP. Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci. 1999;55:1015-28.
43. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-5.
44. Chong CR, Law G, Neil CJ, Nguyen TH, Horowitz JD. Dissociation between severity of takotsubo cardiomyopathy and presentation with shock or hypotension. Clin Cardiol. 2013;36:401-6.
45. Lee DI, Vahebi S, Tocchetti CG, Barouch LA, Solaro RJ, Takimoto E, et al. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKGmediated troponin I phosphorylation. Basic Res Cardiol. 2010; 105:337-47.
46. Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, et al. Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulationinduced cardiac dysfunction and myocardial ischemic injury. J Surg Res. 2006;131:64-72.
47. Valbusa A, Abbadessa F, Giachero C, Vischi M, Zingarelli A, Olivieri R, et al. Long-term follow-up of Tako-Tsubo-like syndrome: a retrospective study of 22 cases. J Cardiovasc Med (Hagerstown). 2008;9:805-9.